ISIN | LU1047627192 |
---|---|
Valorennummer | 23949332 |
Bloomberg Global ID | |
Fondsname | Crossfund Sicav - Crossinvest Swiss Opportunity Fund B-CHF |
Fondsanbieter |
Crossinvest SA
Lugano, Schweiz Telefon: +41 91 911 88 88 E-Mail: info@crossinvest.ch Web: www.crossinvest.ch |
Fondsanbieter | Crossinvest SA |
Vertreter in der Schweiz |
FundPartner Solutions (Suisse) SA Genève 75 |
Distributor(en) |
FundPartner Solutions (Suisse) SA Genève 3 |
Anlagekategorie | Aktienfonds |
EFC-Kategorie | |
Anteilskategorie | Accumulation |
Domizilland | Luxemburg |
Konditionen bei der Ausgabe | Kombination von Ausgabekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Konditionen bei der Rücknahme | Kombination von Rücknahmekommission zugunsten der Fondsleitung und Transaktionsgebühr zugunsten des Fonds |
Investment-Strategie *** | The investment objective of the Sub-Fund is to achieve a long term capital growth in Swiss Francs by pursuing exposure opportunities to the Swiss market. The Sub-Fund will achieve its objective by taking exposure directly and indirectly in any type of equity and equity related securities of companies which are domiciled, headquartered or exercise the predominant part of their activity in Switzerland. |
Besonderheiten |
Aktueller Preis * | 123.46 CHF | 21.11.2024 |
---|---|---|
Vorheriger Preis * | 122.90 CHF | 20.11.2024 |
52 Wochen Hoch * | 131.00 CHF | 30.08.2024 |
52 Wochen Tief * | 111.09 CHF | 28.11.2023 |
NAV * | 123.46 CHF | 21.11.2024 |
Ausgabepreis * | 123.46 CHF | 21.11.2024 |
Rücknahmepreis * | ||
Schlusskurs * | ||
Indikativer Minimalpreis | ||
Fondsvermögen *** | 40'867'490 | |
Anteilsklassevermögen *** | 2'616'251 | |
Trading Information SIX |
YTD-Performance | +6.96% |
29.12.2023 - 21.11.2024
29.12.2023 21.11.2024 |
---|---|---|
1 Monat | -4.34% |
21.10.2024 - 21.11.2024
21.10.2024 21.11.2024 |
3 Monate | -4.01% |
21.08.2024 - 21.11.2024
21.08.2024 21.11.2024 |
6 Monate | -2.70% |
21.05.2024 - 21.11.2024
21.05.2024 21.11.2024 |
1 Jahr | +10.62% |
21.11.2023 - 21.11.2024
21.11.2023 21.11.2024 |
2 Jahre | +9.78% |
21.11.2022 - 21.11.2024
21.11.2022 21.11.2024 |
3 Jahre | -8.93% |
22.11.2021 - 21.11.2024
22.11.2021 21.11.2024 |
5 Jahre | +10.09% |
21.11.2019 - 21.11.2024
21.11.2019 21.11.2024 |
Kapitalbeteiligungsquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteil am Gesamtvermögen in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Immobilienquote in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Novartis AG Registered Shares | 9.69% | |
---|---|---|
Roche Holding AG | 9.15% | |
Nestle SA | 8.97% | |
ABB Ltd | 5.58% | |
UBS Group AG | 5.00% | |
Zurich Insurance Group AG | 4.87% | |
Siegfried Holding AG | 3.70% | |
Givaudan SA | 3.45% | |
Alcon Inc | 3.05% | |
Holcim Ltd | 3.01% | |
Letzte Daten-Aktualisierung | 31.07.2024 |
TER | |
---|---|
Datum TER | |
Performance Fee *** | 20.00% |
PTR | |
Max. Management Fee *** | 1.70% |
Ongoing Charges *** | 2.25% |
SRRI ***
|
|
Datum SRRI *** | 31.10.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |